Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
28
FUNI Quote, Financials, Valuation and Earnings
Last price:
$0.03
Seasonality move
:
-3.66%
Day range:
$0.03 - $0.03
52-week range:
$0.01 - $0.04
Dividend yield:
0%
P/E ratio:
4.88x
P/S ratio:
1.16x
P/B ratio:
--
Volume:
15.2K
Avg. volume:
115.3K
1-year change:
-7.58%
Market cap:
$5M
Revenue:
--
EPS (TTM):
-$0.02
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Hypha Labs, Inc. has -- downside to fair value with a price target of -- per share.
FUNI vs. S&P 500
-
Over the past 5 trading days, Hypha Labs, Inc. has overperformed the S&P 500 by 1.47% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Hypha Labs, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Hypha Labs, Inc. revenues have been falling on a year-over-year basis for 4 quarters in a row. In the most recent quarter Hypha Labs, Inc. reported revenues of --.
Earnings Growth
-
Hypha Labs, Inc. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Hypha Labs, Inc. reported earnings per share of -$0.00.
Enterprise value:
7M
EV / Invested capital:
-11.63x
Price / LTM sales:
1.16x
EV / EBIT:
--
EV / Revenue:
1.85x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
-14.33x
Price / Operating cash flow:
17.26x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
-$48.9K
Return On Assets:
-644.99%
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
-28992.29%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2024-12-31 | 2025-12-31 | |
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -$59.3K | -$48.9K | -$4.4K | -$11.7K | |
| Operating Income | -$421.2K | -$3M | -$2.1M | -$1.3M | -$475K | |
| EBITDA | -$421.2K | -$2.9M | -$2.1M | -$1.3M | -$463.3K | |
| Diluted EPS | $0.01 | -$0.02 | -$0.02 | -$0.01 | -$0.00 | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.1M | $508.3K | $872.4K | $82.7K | $61K | |
| Total Assets | $2.1M | $1.2M | $1.5M | $258.6K | $391.6K | |
| Current Liabilities | $2.5M | $2M | $3.1M | $1.5M | $1.3M | |
| Total Liabilities | $3.6M | $3.7M | $3.2M | $1.5M | $2.7M | |
| Total Equity | -$1.5M | -$2.5M | -$1.7M | -$1.2M | -$2.4M | |
| Total Debt | $2.9M | $2.6M | $2.4M | $1.1M | $1.7M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2024-12-31 | 2025-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $160K | -$1.2M | -$457.3K | -$73K | -$150.2K | |
| Cash From Investing | $154.3K | $2.2M | -$31.2K | -$1.7K | -- | |
| Cash From Financing | -$161.9K | -$1.3M | $494.8K | $20.1K | $155K | |
| Free Cash Flow | $160K | -$1.2M | -$488.5K | -$74.7K | -$150.2K | |
FUNI
Sector
Market Cap
$5M
$320.3M
Price % of 52-Week High
76.25%
72.33%
Dividend Yield
0%
0%
Shareholder Yield
-4.11%
2.22%
1-Year Price Total Return
-7.58%
-4.32%
Beta (5-Year)
1.235
0.521
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$0.03
200-day SMA
Sell
Level
$0.03
Bollinger Bands (100)
Sell
Level
0.02 - 0.04
Chaikin Money Flow
Buy
Level
1.5M
20-day SMA
Sell
Level
$0.03
Relative Strength Index (RSI14)
Sell
Level
45.78
ADX Line
Sell
Level
56.34
Williams %R
Neutral
Level
-40.2299
50-day SMA
Sell
Level
$0.04
MACD (12, 26)
Sell
Level
0.00
25-day Aroon Oscillator
Sell
Level
-20
On Balance Volume
Neutral
Level
132.1K
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-110.9456)
Sell
CA Score
(Annual)
Level (-47.5555)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (8)
Sell
Ohlson Score
Level (67.5502)
--
Piotroski F Score
(Annual)
Level (--)
Sell
Quality Ratio Score
Level (1)
Sell
Fundamental Score
Level (1)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Hypha Labs, Inc. engages in the research, development, and commercialization of a bioreactor. The firm bioreactor is a home appliance designed to accelerate the production of functional mushrooms. The company was founded on October 5, 2010 and is headquartered in Las Vegas, NV.
Stock Forecast FAQ
In the current month, FUNI has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The FUNI average analyst price target in the past 3 months is --.
-
Where Will Hypha Labs, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Hypha Labs, Inc. share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Hypha Labs, Inc.?
Analysts are divided on their view about Hypha Labs, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Hypha Labs, Inc. is a Sell and believe this share price will rise from its current level to --.
-
What Is Hypha Labs, Inc.'s Price Target?
The price target for Hypha Labs, Inc. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is FUNI A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Hypha Labs, Inc. is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of FUNI?
You can purchase shares of Hypha Labs, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Hypha Labs, Inc. shares.
-
What Is The Hypha Labs, Inc. Share Price Today?
Hypha Labs, Inc. was last trading at $0.03 per share. This represents the most recent stock quote for Hypha Labs, Inc.. Yesterday, Hypha Labs, Inc. closed at $0.03 per share.
-
How To Buy Hypha Labs, Inc. Stock Online?
In order to purchase Hypha Labs, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get FUNI Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
FUNI
Sector
P/E ratio
4.88x
17.69x
PEG ratio
0.00x
0.10x
P/B ratio
--
1.34x
Price / LTM sales
1.16x
0.58x
Growth Metrics
FUNI
Sector
Revenue growth
--
3.1%
Earnings growth
68.22%
-2.58%
Revenue (5-year growth)
-100%
4.13%
Earnings forecast
--
$0.27
Profitability
FUNI
Sector
Profitability FY 2025
-$41.6K
$272.6M
Return on invested capital
-28992.29%
3.28%
Return on assets
-644.99%
2.12%
Return on equity
--
5.69%
Earnings Date
Last Earnings Date
Mar
5
Next Earnings Date
Mar
5
Estimated Next Earnings Date
Jun
4
Balance Sheet
FUNI
Sector
Total cash
$42.9K
$134.7M
Short term investments
--
$40.6M
Total assets
$409.2K
$1.1B
Long term debt
$1.7M
$31.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
49
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 37x
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Sell
42
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Buy
93
NBTX alert for Mar 5
Nanobiotix SA [NBTX] is down 5.4% over the past day.
Sell
45
MRNA alert for Mar 5
Moderna, Inc. [MRNA] is down 7.99% over the past day.
Buy
77
SSRM alert for Mar 5
SSR Mining, Inc. [SSRM] is down 7.22% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
